Skip to nav Skip to content
Stephen  Rosenberg

Stephen Rosenberg, MD, MS

Director of MRI Guided Radiation Therapy
4.9 (75)

Specialty: Radiation Oncology

Program: Radiation Oncology

Language(s): English

  • Overview

    Cancer Focus:
    Lung Cancer, Mesothelioma, Pancoast Tumor, Thymoma

    Dr. Stephen Rosenberg is an Assistant Member in the Section of Thoracic Oncology of the Moffitt Cancer Center Department of Radiation Oncology. He grew up in Medford, New Jersey and graduated from Brown University with a Bachelor of Science in Biology. He earned a Master’s of Science in Clinical and Translational Research at Rutgers University in combination with his Medical Degree. During medical school, he was named a Howard Hughes Medical Institute Research Fellow. He went on to complete his medical internship at Memorial Sloan Kettering Cancer Center, where he was named the Suzanne Munson Intern of the Year. He completed his residency in radiation oncology at the University of Wisconsin where he also served as Chief Resident. Dr. Rosenberg’s clinical focus is the treatment of patients with thoracic malignancies. He is interested in combining radiation with immunomodulatory drugs and targeted therapies to improve outcomes. Dr. Rosenberg also pursues research with a special focus on MRI-guided radiation. He is interested in utilizing radiomics and genomics as part of his research efforts. His work is part of the FORT (Future of Radiation Therapy) Departmental research program aimed at personalizing radiation therapy using novel approaches to improve local control of tumors and decrease side effects for patients.

    Education & Training


    • Memorial Sloan Kettering Cancer Center - Internship
    • University of Wisconsin - Residency

    Medical School:

    • Rutgers Robert Wood Johnson Medical School - MD
  • Publications

    • Mills M, Kotecha R, Herrera R, Kutuk T, Fahey M, Wuthrick E, Grass GD, Hoffe S, Frakes J, Chuong MD, Rosenberg SA. Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases. Clin Transl Radiat Oncol. 2024 Mar.45:100719. Pubmedid: 38292332. Pmcid: PMC10824679.
    • Naghavi AO, Bryant JM, Kim Y, Weygand J, Redler G, Sim AJ, Miller J, Coucoules K, Michael LT, Gloria WE, Yang G, Rosenberg SA, Ahmed K, Bui MM, Henderson-Jackson EB, Lee A, Lee CD, Gonzalez RJ, Feygelman V, Eschrich SA, Scott JG, Torres-Roca J, Latifi K, Parikh N, Costello J. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma. BMC Cancer. 2024 Apr.24(1):437. Pubmedid: 38594603. Pmcid: PMC11003059.
    • Weygand J, Armstrong T, Bryant JM, Andreozzi JM, Oraiqat IM, Nichols S, Liveringhouse CL, Latifi K, Yamoah K, Costello JR, Frakes JM, Moros EG, El Naqa IM, Naghavi AO, Rosenberg SA, Redler G. Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator. Phys Imaging Radiat Oncol. 2023 Oct.28:100505. Pubmedid: 38045642. Pmcid: PMC10692914.
    • Bryant JM, Doniparthi A, Weygand J, Cruz-Chamorro R, Oraiqat IM, Andreozzi J, Graham J, Redler G, Latifi K, Feygelman V, Rosenberg SA, Yu HM, Oliver DE. Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions. Cancers (Basel). 2023 Oct.15(21). Pubmedid: 37958374. Pmcid: PMC10649155.
    • Liveringhouse C, Netzley A, Bryant JM, Linkowski LC, Weygand J, Sandoval ML, Dohm A, Dookhoo M, Kelley S, Rosenberg SA, Latifi K, Torres-Roca JF, Johnstone PAS, Yamoah K, Grass GD. Trimodal Therapy Using an MR-guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer. Adv Radiat Oncol. 2023 May.8(6):101268. Pubmedid: 38047218. Pmcid: PMC10692296.
    • Sandoval ML, Sim AJ, Bryant JM, Bhandari M, Wuthrick EJ, Perez BA, Dilling TJ, Redler G, Andreozzi J, Nardella L, Feygelman V, Latifi K, Rosenberg SA. Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions. JTO Clin Res Rep. 2023 May.4(5):100488. Pubmedid: 37159821. Pmcid: PMC10163640.
    • Bryant JM, Weygand J, Keit E, Cruz-Chamorro R, Sandoval ML, Oraiqat IM, Andreozzi J, Redler G, Latifi K, Feygelman V, Rosenberg SA. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions. Cancers (Basel). 2023 Mar.15(7). Pubmedid: 37046741. Pmcid: PMC10093051.
    • Oliver DE, Laborde JM, Singh DP, Milano MT, Videtic GM, Williams GR, Lariviere MJ, Chan JW, Peters GW, Decker RH, Samson P, Robinson CG, Breen WG, Owen D, Tian S, Higgins KA, Almeldin D, Jabbour SK, Wang F, Grass GD, Perez BA, Dilling TJ, Strosberg J, Rosenberg SA. Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience. Int J Radiat Oncol Biol Phys. 2023 Jul.116(4):849-857. Pubmedid: 36708788.
    • Liveringhouse CL, Latifi K, Asous AG, Lam NB, Rosenberg SA, Dilling TJ, MacMillan GV, Chiappori AA, Haura EB, Creelan B, Gray JE, Tanvetyanon T, Shafique MR, Saltos AN, Weiner AA, Clarke J, Kelsey CR, Kim S, Caudell JJ, Rose TA, Conejo-Garcia JR, Li J, Schell MJ, Antonia SJ, Perez BA. Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023 Jul.116(4):837-848. Pubmedid: 36657497.
    • Bryant JM, Sim AJ, Feygelman V, Latifi K, Rosenberg SA. Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance. Front Oncol. 2023 Jan.13:1061854. Pubmedid: 36776319. Pmcid: PMC9911810.
    • Chuong MD, Clark MA, Henke LE, Kishan AU, Portelance L, Parikh PJ, Bassetti MF, Nagar H, Rosenberg SA, Mehta MP, Refaat T, Rineer JM, Smith A, Seung S, Zaki BI, Fuss M, Mak RH. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments. Clin Transl Radiat Oncol. 2023 Jan.38:161-168. Pubmedid: 36466748. Pmcid: PMC9712826.
    • Dudas D, Saghand PG, Dilling TJ, Perez BA, Rosenberg SA, Naqa IE. Deep Learning-Guided Dosimetry for Mitigating Local Failure of Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Dec. Pubmedid: 38056778.
    • Song EY, Chuang J, Frakes JM, Dilling T, Quinn JF, Rosenberg S, Johnstone P, Harrison L, Hoffe SE. Developing a Dedicated Leadership Curriculum for Radiation Oncology Residents. J Cancer Educ. 2022 Oct.37(5):1446-1453. Pubmedid: 33619686.
    • Graham JA, Redler G, Delozier KB, Yu HM, Oliver DE, Rosenberg SA. Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator. J Appl Clin Med Phys. 2022 Jun.23(6):e13587. Pubmedid: 35344266. Pmcid: PMC9195042.
    • Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L. Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. Pract Radiat Oncol. 2022 Jun.12(5):e355-e362. Pubmedid: 35644469.
    • Sim AJ, Hoffe SE, Latifi K, Palm RF, Feygelman V, Leuthold S, Dookhoo M, Dennett M, Rosenberg SA, Frakes JM. A Practical Workflow for Magnetic Resonance-Guided Stereotactic Body Radiation Therapy to the Pancreas. Pract Radiat Oncol. 2022 Jul.13(1):e45-e53. Pubmedid: 35901947.
    • Ericsson-Szecsenyi R, Zhang G, Redler G, Feygelman V, Rosenberg S, Latifi K, Ceberg C, Moros EG. Robustness Assessment of Images From a 0.35T Scanner of an Integrated MRI-Linac: Characterization of Radiomics Features in Phantom and Patient Data. Technol Cancer Res Treat. 2022 Jan.21. Pubmedid: 35521966. Pmcid: PMC9083059.
    • Johnstone PAS, Kerstiens J, Wasserman S, Rosenberg SA. MRI-Linac Economics II: Rationalizing Schedules. J Clin Med. 2022 Feb.11(3). Pubmedid: 35160318. Pmcid: PMC8836757.
    • Turner K, Brownstein NC, Thompson Z, El Naqa I, Luo Y, Jim HSL, Rollison DE, Howard R, Zeng D, Rosenberg SA, Perez B, Saltos A, Oswald LB, Gonzalez BD, Islam JY, Alishahi Tabriz A, Zhang W, Dilling TJ. Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy. Radiother Oncol. 2022 Feb.167:116-121. Pubmedid: 34953934. Pmcid: PMC8934278.
    • Linkowski LC, Sim AJ, Redler G, Brohl AS, Rosenberg SA, Wuthrick EJ. Delivery of Online Adaptive MRI-Guided Radiation Therapy for a Deaf Patient. Cureus. 2022 Aug.14(8):e27558. Pubmedid: 36059359. Pmcid: PMC9429821.
    • Blitzer GC, Parekh AD, Chen S, Taparra K, Kahn JM, Fields EC, Stahl JM, Rosenberg SA, Buatti JM, Laucis AM, Wang Y, Mayhew DL, McDonald AM, Harari PM, Brower JV. Why an Increasing Number of Unmatched Residency Positions in Radiation Oncology? A Survey of Fourth-Year Medical Students. Adv Radiat Oncol. 2021 Sep.6(5):100743. Pubmedid: 34466713. Pmcid: PMC8385400.
    • Palm RF, Eicher KG, Sim AJ, Peneguy S, Rosenberg SA, Wasserman S, Johnstone PAS. Assessment of MRI-Linac Economics under the RO-APM. J Clin Med. 2021 Oct.10(20). Pubmedid: 34682829. Pmcid: PMC8539760.
    • Rosenberg SA, Mak R, Kotecha R, Loo BW, Senan S. The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window. J Thorac Oncol. 2021 Oct.16(10):e79-e80. Pubmedid: 34561039.
    • Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Front Oncol. 2021 May.11:628155. Pubmedid: 34046339. Pmcid: PMC8144850.
    • Tomaszewski MR, Dominguez-Viqueira W, Ortiz A, Shi Y, Costello JR, Enderling H, Rosenberg SA, Gillies RJ. Heterogeneity analysis of MRI T2 maps for measurement of early tumor response to radiotherapy. Nmr Biomed. 2021 Mar.34(3):e4454. Pubmedid: 33325086.
    • Rosenberg SA, Denu RA, Francis D, Hullett CR, Fisher M, Schuster JM, Bassetti MF, Kimple RJ. RTAnswers Online Patient Education Materials Deviate From Recommended Reading Levels. Appl Radiat Oncol. 2021 Jun.7(2):26-30. Pubmedid: 34169120. Pmcid: PMC8221236.
    • Sandoval ML, Youssef I, Latifi K, Grass GD, Torres-Roca J, Rosenberg S, Yamoah K, Johnstone PA. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results. J Clin Med. 2021 Jul.10(15). Pubmedid: 34362179. Pmcid: PMC8347281.
    • Koo J, Nardella L, Degnan M, Andreozzi J, Yu HM, Penagaricano J, Johnstone PAS, Oliver D, Ahmed K, Rosenberg SA, Wuthrick E, Diaz R, Feygelman V, Latifi K, Moros EG, Redler G. Triggered kV Imaging During Spine SBRT for Intrafraction Motion Management. Technol Cancer Res Treat. 2021 Jan.20. Pubmedid: 34855577. Pmcid: PMC8649431.
    • Perez BA, Kim S, Wang M, Karimi AM, Powell C, Li J, Dilling TJ, Chiappori A, Latifi K, Rose T, Lannon A, MacMillan G, Saller J, Grass GD, Rosenberg S, Gray J, Haura E, Creelan B, Tanvetyanon T, Saltos A, Shafique M, Boyle TA, Schell MJ, Conejo-Garcia JR, Antonia SJ. Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2021 Feb.109(2):425-435. Pubmedid: 33002543. Pmcid: PMC8465780.
    • Tomaszewski MR, Latifi K, Boyer E, Palm RF, El Naqa I, Moros EG, Hoffe SE, Rosenberg SA, Frakes JM, Gillies RJ. Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer. Radiat Oncol. 2021 Dec.16(1):237. Pubmedid: 34911546. Pmcid: PMC8672552.
    • Brower JV, Chen S, Ritter A, Liauw SL, Rosenberg SA, Reddy AV, Golden DW, Gillespie EF, Mattes MD. Comfort Level of US Radiation Oncology Graduates: Assessment of Transition to Independent Clinical Practice. J Cancer Educ. 2021 Apr.36(2):278-283. Pubmedid: 31728920. Pmcid: PMC7441593.
    • Sim AJ, Frakes JM, Hoffe SE, Wuthrick E, Dilling TJ, Rosenberg S. Novel MR-Guided Radiotherapy Elective Rotation for Radiation Oncology Trainees. Cureus. 2020 Sep.12(9):e10706. Pubmedid: 33133871. Pmcid: PMC7594659.
    • Sim AJ, Kaza E, Singer L, Rosenberg SA. A review of the role of MRI in diagnosis and treatment of early stage lung cancer. Clin Transl Radiat Oncol. 2020 Sep.24:16-22. Pubmedid: 32596518. Pmcid: PMC7306507.
    • Sim AJ, Palm RF, DeLozier KB, Feygelman V, Latifi K, Redler G, Washington IR, Wuthrick EJ, Rosenberg SA. MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases. Clin Transl Radiat Oncol. 2020 Nov.25:102-106. Pubmedid: 33204858. Pmcid: PMC7653008.
    • Sim AJ, Redler G, Peacock J, Naso C, Wasserman S, McNitt KB, Hoffe SE, Johnstone PAS, Harrison LB, Rosenberg SA. Harnessing COVID-Driven Technical Innovations for Improved Multi-Disciplinary Cancer Care in the Post-COVID Era: The Virtual Patient Room. Cancer Control. 2020 Jan.27(1). Pubmedid: 33023342. Pmcid: PMC7791470.
    • Witt JS, Rosenberg SA, Bassetti MF. MRI-guided adaptive radiotherapy for liver tumours: visualising the future. Lancet Oncol. 2020 Feb.21(2):e74-e82. Pubmedid: 32007208.
    • Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, Bassetti MF, Parikh PJ, Lee PP. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019 May.8(5):2123-2132. Pubmedid: 30932367. Pmcid: PMC6536981.
    • Singer L, Rosenberg SA. The Impact of MRI on Radiation Oncology Graduate Medical Education. J Am Coll Radiol. 2019 Jun.16(6):859-863. Pubmedid: 30737161.
    • Blitzer GC, Rosenberg SA, Anderson BM, McCulloch TM, Wieland AM, Hartig GK, Bruce JY, Witek ME, Kimple RJ, Harari PM. Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center. Int J Radiat Oncol Biol Phys. 2018 Sep.102(1):146-148. Pubmedid: 29980415. Pmcid: PMC6089656.
    • Witt JS, Gao RW, Sudmeier LJ, Rosenberg SA, Francis DM, Wallace CR, Das RK, Anderson BM. Low cardiac and left anterior descending coronary artery dose achieved with left-sided multicatheter interstitial-accelerated partial breast irradiation. Brachytherapy. 2018 Sep.18(1):50-56. Pubmedid: 30262411. Pmcid: PMC6338487.
    • Jang S, Rosenberg SA, Bradley KA, Kimple RJ. In Reply to Lin and Golden. Int J Radiat Oncol Biol Phys. 2018 Nov.102(3):672. Pubmedid: 30238905.
    • Gallagher SJ, Rosenberg SA, Francis D, Salamat S, Howard SP, Kimple RJ. Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report and review of the literature. Clin Neurol Neurosurg. 2018 Feb.165:76-80. Pubmedid: 29324399.
    • Jang S, Rosenberg SA, Hullett C, Bradley KA, Kimple RJ. Beyond 'charting outcomes' in the radiation oncology match: analysis of self-reported applicant data. Med Educ Online. 2018 Dec.23(1):1489691. Pubmedid: 29943670. Pmcid: PMC6022246.
    • Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2018 Aug.4(1):142-149. Pubmedid: 30706022. Pmcid: PMC6349638.
    • Schaff EM, Rosenberg SA, Olson SJ, Howard SP, Bradley KA. Bone marrow suppression as a complication of total skin helical tomotherapy in the treatment of mycosis fungoides. Radiat Oncol. 2018 Apr.13(1):67. Pubmedid: 29653544. Pmcid: PMC5899362.
    • Mittauer K, Paliwal B, Hill P, Bayouth JE, Geurts MW, Baschnagel AM, Bradley KA, Harari PM, Rosenberg S, Brower JV, Wojcieszynski AP, Hullett C, Bayliss RA, Labby ZE, Bassetti MF. A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies. Cureus. 2018 Apr.10(4):e2422. Pubmedid: 29872602. Pmcid: PMC5985918.
    • Rosenberg SA, Bradley KA, Kimple RJ. In Reply to Hamstra. Int J Radiat Oncol Biol Phys. 2018 04.100(5):1293-1294. Pubmedid: 29722667.
    • Jang S, Rosenberg SA, Hullet C, Bradley KA, Kimple RJ. Value of Elective Radiation Oncology Rotations: How Many Is Too Many?. Int J Radiat Oncol Biol Phys. 2018 03.100(3):558-559. Pubmedid: 29413271. Pmcid: PMC5806148.
    • Rasheed A, Jabbour SK, Rosenberg S, Patel A, Goyal S, Haffty BG, Yue NJ, Khan A. Motion and volumetric change as demonstrated by 4DCT: The effects of abdominal compression on the GTV, lungs, and heart in lung cancer patients. Pract Radiat Oncol. 2017 Mar.6(5):352-359. Pubmedid: 26922698.
    • Denu RA, Rosenberg SA, Howard SP. Familial Trigeminal Neuralgia Treated with Stereotactic Radiosurgery: A Case Report and Literature Review. J Radiat Oncol. 2017 Jun.6(2):149-152. Pubmedid: 29201285. Pmcid: PMC5705085.
    • Wojcieszynski AP, Hill PM, Rosenberg SA, Hullett CR, Labby ZE, Paliwal B, Geurts MW, Bayliss RA, Bayouth JE, Harari PM, Bassetti MF, Baschnagel AM. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Technol Cancer Res Treat. 2017 Jun.16(3):366-372. Pubmedid: 28168936. Pmcid: PMC5616053.
    • Rosenberg SA, Baschnagel AM, Bagley SJ, Housri N. Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Curr Oncol Rep. 2017 Jan.19(1):5. Pubmedid: 28168606.
    • Rosenberg SA, Kimple RJ. The Second Stain: A Viral Whodunnit. Int J Radiat Oncol Biol Phys. 2017 Dec.99(5):1061. Pubmedid: 29165273.
    • Rosenberg SA, Francis DM, Hullet CR, Morris ZS, Brower JV, Anderson BM, Bradley KA, Bassetti MF, Kimple RJ. Online patient information from radiation oncology departments is too complex for the general population. Pract Radiat Oncol. 2017 Apr.7(1):57-62. Pubmedid: 27663932. Pmcid: PMC5219938.
    • Brower JV, Saha S, Rosenberg SA, Hullett CR, Ian Robins H. Management of leptomeningeal metastases: Prognostic factors and associated outcomes. J Clin Neurosci. 2016 May.27:130-137. Pubmedid: 26778048.
    • Rosenberg SA, Francis D, Hullett CR, Morris ZS, Fisher MM, Brower JV, Bradley KA, Anderson BM, Bassetti MF, Kimple RJ. Readability of Online Patient Educational Resources Found on NCI-Designated Cancer Center Web Sites. J Natl Compr Canc Ne. 2016 Jun.14(6):735-740. Pubmedid: 27283166. Pmcid: PMC7236813.
    • Wojcieszynski AP, Rosenberg SA, Brower JV, Hullett CR, Geurts MW, Labby ZE, Hill PM, Bayliss RA, Paliwal B, Bayouth JE, Harari PM, Bassetti MF. Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. Radiother Oncol. 2016 Feb.118(2):416-418. Pubmedid: 26627702.
    • Setton J, Han J, Kannarunimit D, Wuu YR, Rosenberg SA, DeSelm C, Wolden SL, Jillian Tsai C, McBride SM, Riaz N, Lee NY. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. Oral Oncol. 2016 Feb.53:67-73. Pubmedid: 26675283. Pmcid: PMC4975930.
    • Rosenberg SA, Niglio SA, Salehomoum N, Chan JL, Jeong BS, Wen Y, Li J, Fukui J, Chen S, Shin SS, Goydos JS. Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression. Transl Oncol. 2015 Feb.8(1):1-9. Pubmedid: 25749171. Pmcid: PMC4350641.
    • Deming D, Uboha N, Zafar SY, Rosenberg S, Bassetti M, Glasgow S, Borden EC, Lubner S. Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol. 2015 Dec.42(6):e99-107. Pubmedid: 26615141.
    • Rosenberg SA, Niglio SA, Jo VY, Goydos JS. Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management. Rare Tumors. 2014 Oct.6(4):5573. Pubmedid: 25568750. Pmcid: PMC4274444.
    • Coups EJ, Stapleton JL, Manne SL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Tatum KS, Robinson JK, Natale-Pereira A, Goydos JS. Psychosocial correlates of sun protection behaviors among U.S. Hispanic adults. J Behav Med. 2014 Dec.37(6):1082-1090. Pubmedid: 24532153. Pmcid: PMC4134426.
    • Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon MA, Natale-Pereira A, Goydos JS. Linguistic acculturation and skin cancer-related behaviors among Hispanics in the southern and western United States. JAMA Dermatol. 2013 Jun.149(6):679-686. Pubmedid: 23752366. Pmcid: PMC3689859.
    • Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Natale-Pereira A, Goydos JS. Skin cancer surveillance behaviors among US Hispanic adults. J Am Acad Dermatol. 2013 Apr.68(4):576-584. Pubmedid: 23182066. Pmcid: PMC3608735.
    • Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, Chan JL, Namkoong J, Goydos JS, Chen S. Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. Clin Cancer Res. 2011 Nov.17(22):7080-7092. Pubmedid: 21844014. Pmcid: PMC3218300.
    • Nabatian AS, Shah KN, Iofel E, Rosenberg S, Javidian P, Pappert A, Milgraum SS. Asymptomatic granulomatous vulvitis and granulomatous cheilitis in childhood: the need for Crohn disease workup. J Pediatr Gastroenterol Nutr. 2011 Jul.53(1):100-101. Pubmedid: 21694543.
    • Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res. 2011 Apr.317(7):920-931. Pubmedid: 21256126. Pmcid: PMC3066145.
    • Walker EJ, Rosenberg SA, Wands JR, Kim M. Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma. For Immunopathol Dis Therap. 2011.2(2):195-204. Pubmedid: 21984963. Pmcid: PMC3188396.
    • Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA, Goydos JS. The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol. 2010 Sep.130(9):2240-2249. Pubmedid: 20505744. Pmcid: PMC4004181.
  • Grants

    Title: Artificial Intelligence for Effective MR-Linac Adaptive Radiotherapy
    Sponsor: ViewRay Technologies
    PI: El Naqa, I., CO-PI: Rosenberg, S.
    Title: Validation of the Radiosensitivity Index (RSI) as a Predictive Biomarker in Non-small Cell Lung Cancer Samples from RTOG Phase 3 Trial 0617
    Sponsor: Moffitt Cancer Center
    PI (Contact): Rosenberg, S.
  • Patient Comments

    Overall Satisfaction


    75 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey



    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor